Possible involvement of protein kinase C activation in differentiation of human umbilical vein endothelium-derived cell into smooth muscle-like cell

被引:10
作者
Ishisaki, A [1 ]
Tsunobuchi, H
Nakajima, K
Imamura, T
机构
[1] Gifu Univ, Sch Med, Dept Pharmacol, Gifu 5008705, Japan
[2] AIST, Age Dimens Res Ctr, Tsukuba, Ibaraki, Japan
[3] AIST, Collaborat Interdisciplinary Res Team, Tsukuba, Ibaraki, Japan
关键词
protein kinase C; endothelium-derived cell; smooth muscle-like cell; fibroblast growth factor;
D O I
10.1016/j.biolcel.2004.04.012
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We previously reported that when deprived of fibroblast growth factor, human umbilical vein endothelium-derived cells (HUVE-DCs) are capable of differentiating into smooth muscle-like cells through activin A-induced, Smad-dependent signaling, and that maintenance of the endothelial-cell phenotype and differentiation into smooth muscle-like cells are reciprocally controlled by fibroblast growth factor-1 and activin A (Ishisaki et al., 2003). Here, we examined how protein kinase C (PKC), which plays pivotal roles in the regulation of cellular proliferation and differentiation in numerous cell types, might affect the above differentiation. We found that phorbol-12-myristate-13-acetate-induced down-regulations of some PKCs accompany suppressions of the expressions of smooth muscle cell markers in HUVE-DCs deprived of fibroblast growth factor. Moreover, the PKC-inhibitors Go6850 and Go6983 suppressed the differentiation of HUVE-DCs into smooth muscle-like cells. These results strongly suggest that activation of PKC is involved in the above differentiation. (C) 2004 Elsevier SAS. All rights reserved.
引用
收藏
页码:499 / 508
页数:10
相关论文
共 58 条
[21]   HEPARAN-SULFATE AND HEPARIN AS A POTENTIATOR OR A SUPPRESSOR OF GROWTH OF NORMAL AND TRANSFORMED VASCULAR ENDOTHELIAL-CELLS [J].
IMAMURA, T ;
MITSUI, Y .
EXPERIMENTAL CELL RESEARCH, 1987, 172 (01) :92-100
[22]   Human umbilical vein endothelium-derived cells retain potential to differentiate into smooth muscle-like cells [J].
Ishisaki, A ;
Hiyashi, H ;
Li, AJ ;
Imamura, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (02) :1303-1309
[23]   Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization [J].
Isner, JM ;
Asahara, T .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (09) :1231-1236
[24]   Mitochondrial targeting of JNK/SAPK in the phorbol ester response of myeloid leukemia cells [J].
Ito, Y ;
Mishra, NC ;
Yoshida, K ;
Kharbanda, S ;
Saxena, S ;
Kufe, D .
CELL DEATH AND DIFFERENTIATION, 2001, 8 (08) :794-800
[25]   Protein kinase C isozymes and substrates [J].
Jaken, S .
CURRENT OPINION IN CELL BIOLOGY, 1996, 8 (02) :168-173
[26]   Protein kinase C is regulated in vivo by three functionally distinct phosphorylations [J].
Keranen, LM ;
Dutil, EM ;
Newton, AC .
CURRENT BIOLOGY, 1995, 5 (12) :1394-1403
[27]  
KISHIMOTO A, 1989, J BIOL CHEM, V264, P4088
[28]   ENDOTHELIAL-CELL MARKERS IN VASCULAR NEOPLASMS - AN IMMUNOHISTOCHEMICAL STUDY COMPARING FACTOR-VIII-RELATED ANTIGEN, BLOOD-GROUP SPECIFIC ANTIGENS, 6-KETO-PGF1-ALPHA, AND ULEX-EUROPAEUS-1 LECTIN [J].
LITTLE, D ;
SAID, JW ;
SIEGEL, RJ ;
FEALY, M ;
FISHBEIN, MC .
JOURNAL OF PATHOLOGY, 1986, 149 (02) :89-95
[29]   PKCα-mediated ERK, JNK and p38 activation regulates the myogenic program in human rhabdomyosarcoma cells [J].
Mauro, A ;
Ciccarelli, C ;
De Cesaris, P ;
Scoglio, A ;
Bouché, M ;
Molinaro, M ;
Aquino, A ;
Zani, BM .
JOURNAL OF CELL SCIENCE, 2002, 115 (18) :3587-3599
[30]   LOCALIZATION OF FACTOR-VIII VONWILLEBRAND-FACTOR AND GLIAL FIBRILLARY ACIDIC PROTEIN IN THE HEMANGIOBLASTOMA - IMPLICATIONS FOR STROMAL CELL HISTOGENESIS [J].
MCCOMB, RD ;
JONES, TR ;
PIZZO, SV ;
BIGNER, DD .
ACTA NEUROPATHOLOGICA, 1982, 56 (03) :207-213